Mechanisms of Diseases
A section of Journal of Personalized Medicine (ISSN 2075-4426).
Section Information
Aim
The “Mechanisms of Diseases” section of the Journal of Precision Medicine aims to disseminate leading-edge scholarship on individual or personalized biomolecular mechanisms related to disease, disease progression, persistent disease remission, mechanisms of resistance, mechanisms of outstanding response, and mechanisms of regular response to therapy. We emphasize translational research, requiring validation using human cohorts, human tissues, or human-derived data, either retrospectively, prospectively, or through meta-analyses. We encourage submissions that explore complex biomolecular interactions and patterns, including those spanning different biological scales, exploring synergistic and antagonistic effects of distinct biomolecular mechanisms that may interact in an individual manner and confer paradoxical resistance of or risk factors not more otherwise explained by simple additive and subtractive effects of risks. We strongly encourage the submission of articles that focus on predictive analytics and biomarkers, including those that involve multiple variables (e.g., multi-omics, biomolecular pathways, clinical imaging, clinical data, or a combination of these ) rooted in causal biomolecular mechanisms.
Scope
- Individualised Biomolecular Mechanisms of Disease/Insights into the underlying biomolecular mechanisms contributing to the development of specific diseases.
- Individual Disease Progression/Investigation into the biomolecular mechanisms that drive the progression of diseases.
- Persistent Individual Disease Remission/Explore the mechanisms responsible for maintaining disease remission over extended periods.
- Mechanisms of Individual Resistance to Therapy/Address the biomolecular mechanisms that underlie resistance to therapies or interventions.
- Mechanisms of Exceptional Individual Response to Therapy/Elucidate the biomolecular mechanisms that lead to exceptional responses to treatments.
- Mechanisms Explaining Individualized Probability of Response to Therapy/Focus on the biomolecular mechanisms associated with typical responses to therapeutic interventions.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Diabetes Mellitus: Current Research and Future Perspectives, 2nd Edition (Deadline: 30 March 2026)
- Inflammation and Immunity in Cardiovascular Diseases (Deadline: 30 April 2026)
- Neuroinflammation and Multiple Sclerosis: Pathogenesis to Personalized Therapy (Deadline: 10 May 2026)
- Retinal Diseases: Mechanisms, Diagnosis and Treatments (Deadline: 25 May 2026)
- Breast Cancer: Molecular Highlights, Emerging Therapies, and Promising Strategies (Deadline: 25 May 2026)
- Child and Adolescent Psychiatry: Latest Research, Prevention and Treatment (Deadline: 25 June 2026)
- Novel Challenges and Advances in Respiratory Diseases (Deadline: 30 June 2026)
- AI and Precision Medicine: Innovations and Applications (Deadline: 30 June 2026)
- Pathogenesis and Personalized Management of Asthma (Deadline: 20 July 2026)
- Personalized Medicine in Metabolism Disorders (Deadline: 31 July 2026)
- Gestational Diabetes: Challenges and Cutting-Edge Research (Deadline: 25 August 2026)
- Pharmacogenetics and Synaptic Plasticity in Neurological Disorders: From Mechanisms to Therapies (Deadline: 15 September 2026)
- Innovations in Airway Diseases (Deadline: 30 September 2026)
- Current Status and Future Prospects of Histopathology in Cancer Diagnosis (Deadline: 30 September 2026)
- Advancing Personalized Medicine: Targeting Oxidative Stress in Neurodegenerative Diseases (Deadline: 31 October 2026)
- Oxidative Stress and Antioxidant Therapy in Diseases (Deadline: 30 November 2026)
- Regenerative Medicine in Cardiovascular Disease (Deadline: 31 December 2026)
- Advances in Atrial Fibrillation and Cardiac Arrhythmias: Mechanisms, Diagnosis, and Therapy (Deadline: 31 December 2026)
- Personalized Medicine in Cardiovascular and Metabolic Diseases (Deadline: 31 December 2026)